Neurogenetics: Insights into degenerative diseases and approaches to schizophrenia

Clinical Neuroscience Research

Volumn 5, Issue 1 SPEC. ISS., 2005, Pages 3-14

  Ross, Christopher A ^a,b   Margolis, Russell L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CMSC 8 121 ^*  (United States)

Author keywords

Bipolar disorder; Huntington's disease; Neurodegeneration; Neurodevelopment; Parkinson's disease; Psychosis; Schizophrenia; Translocation; Trinucleotide; Triplet

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; ATAXIN 3; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CATECHOL METHYLTRANSFERASE; CYTOSKELETON PROTEIN; DEXTRO AMINO ACID OXIDASE; DYSTROBREVIN; GENE PRODUCT; HUNTINGTIN; LEVODOPA; NEU DIFFERENTIATION FACTOR; PARKIN; PROTEIN DISC1; PROTEIN KINASE C; RGS PROTEIN; TATA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ALPHA CHAIN; ALZHEIMER DISEASE; BIPOLAR DISORDER; DEGENERATIVE DISEASE; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUNTINGTON CHOREA; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOGENESIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; TRISOMY 21;

EID: 24344471682     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2005.07.001     Document Type: Article

References (148)

1. C.A. Ross R.L. Margolis A. Rosenblatt N.G. Ranen M.W. Becher E. Aylward Huntington disease and the related disorder, dentatorubral- pallidoluysian atrophy (DRPLA) Medicine (Baltimore) 76 5 1997 305-338
2. G. Bates P.S. Harper L. Jones Huntington's disease 3rd ed 2002 Oxford University Press Oxford; New York
3. F. Squitieri M. Cannella P. Giallonardo V. Maglione C. Mariotti M.R. Hayden Onset and pre-onset studies to define the Huntington's disease natural history Brain Res Bull 56 3-4 2001 233-238
4. R.L. Margolis C.A. Ross Diagnosis of Huntington disease Clin Chem 49 10 2003 1726-1732
5. L. Schols P. Bauer T. Schmidt T. Schulte O. Riess Autosomal dominant cerebellar ataxias: Clinical features, genetics, and pathogenesis Lancet Neurol 3 5 2004 291-304
6. C.M. Gomez S.H. Subramony Dominantly inherited ataxias Semin Pediatr Neurol 10 3 2003 210-222
7. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971-983
8. A. Rosenblatt N. Ranen D.C. Rubinsztein O.C. Stine R.L. Margolis M.V. Wagster et al. Characteristics of patients with clinical features similar to Huntington's disease, but negative for expanded CAG repeats in huntingtin Neurology 1998
9. R. Koide T. Ikeuchi O. Onorodera H. Tanaka S. Igarashi E. Endo et al. Unstable expansion of CAG repeat in herediatry dentatorubral pallidoluysian atrophy (DRPLA) Nat Genet 6 1994 9-12
10. S. Nagafuchi H. Yanagisawa K. Soto T. Shirayama E. Ohsaki M. Bundo et al. Dentatorubral and pallidoluysian atrophy is caused by an expansion of an unstable CAG trinucleotide repeat on chromosome 12p Nature Genetics 6 1994 14-18
11. S. Tsuji Dentatorubral-pallidoluysian atrophy (DRPLA) J Neural Transm Suppl 58 2000 167-180
12. M.W. Becher D.C. Rubinsztein J. Leggo M.V. Wagster O.C. Stine N.G. Ranen et al. Clinical and neuropathological findings in genetically confirmed North American and European pedigrees Mov Disord 12 4 1997 519-530 [Dentatorubral and pallidoluysian atrophy (DRPLA)].
13. K. Tsuchiya S. Oyanagi K. Arima K. Ikeda T. Akashi S. Ando et al. Dentatorubropallidoluysian atrophy: Clinicopathological study of dementia and involvement of the nucleus basalis of Meynert in seven autopsy cases Acta Neuropathol (Berl) 96 5 1998 502-508
14. S.E. Holmes E. O'Hearn A. Rosenblatt C. Callahan H.S. Hwang R.G. Ingersoll-Ashworth et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2 Nat Genet 29 4 2001 377-378
15. R.L. Margolis E. O'Hearn A. Rosenblatt V. Willour S.E. Holmes M.L. Franz et al. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion Ann Neurol 50 3 2001 373-380
16. R.L. Margolis The spinocerebellar ataxias: Order emerges from chaos Curr Neurol Neurosci Rep 2 5 2002 447-456
17. G. David N. Abbas G. Stevanin A. Durr G. Yvert G. Cancel et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion Nat Genet 17 1 1997 65-70
18. E. O'Hearn S.E. Holmes P.C. Calvert C.A. Ross R.L. Margolis SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion Neurology 56 3 2001 299-303
19. D.H. Geschwind S. Perlman C.P. Figueroa L.J. Treiman S.M. Pulst The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia Am J Hum Genet 60 4 1997 842-850
20. H.L. Paulson Spinocerebellar ataxia type 3/Machado-Joseph disease In: D.C. Rubinsztein M.R. Hayden editors. Analysis of triplet repeat disorders 1998 Bios Oxford 129-144
21. A. Rolfs A.H. Koeppen I. Bauer P. Bauer S. Buhlmann H. Topka et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) Ann Neurol 54 3 2003 367-375
22. G. Stevanin H. Fujigasaki A.S. Lebre A. Camuzat C. Jeannequin C. Dode et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes Brain 126 Pt 7 2003 1599-1603
23. S. Furtado H. Payami P.J. Lockhart M. Hanson J.G. Nutt A.A. Singleton et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2) Mov Disord 19 6 2004 622-629
24. K. Gwinn-Hardy A. Singleton P. O'Suilleabhain M. Boss D. Nicholl A. Adam et al. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family Arch Neurol 58 2 2001 296-299
25. Y.R. Wu H.Y. Lin C.M. Chen K. Gwinn-Hardy L.S. Ro Y.C. Wang et al. Genetic testing in spinocerebellar ataxia in Taiwan: Expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease Clin Genet 65 3 2004 209-214
26. A.R. La Spada E.M. Wilson D.B. Lubahn A.E. Harding K.H. Fischbeck Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy Nature 352 1991 77-79
27. G. Bates Huntingtin aggregation and toxicity in Huntington's disease Lancet 361 9369 2003 1642-1644
28. A. Michalik C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum Mol Genet 12 2003 R173-R186 [Spec No 2]
29. C. Ross Polyglutamine pathogenesis. Emergence of unifying mechanisms for Huntington's disease and related disorders Neuron 35 5 2002 819
30. M. DiFiglia E. Sapp K.O. Chase S.W. Davies G.P. Bates J.P. Vonsattel et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990-1993
31. F. Saudou S. Finkbeiner D. Devys M.E. Greenberg Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions Cell 95 1 1998 55-66
32. M. Arrasate S. Mitra E.S. Schweitzer M.R. Segal S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 7010 2004 805-810
33. S. Chen V. Berthelier W. Yang R. Wetzel Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity J Mol Biol 311 1 2001 173-182
34. C.A. Ross M.A. Poirier Protein aggregation and neurodegenerative disease Nat Med 10 2004 S10-S17
35. J. Hardy D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 5580 2002 353-356
36. L. Bertram R.E. Tanzi Alzheimer's disease: One disorder, too many genes? Hum Mol Genet 13 2004 R135-R141
37. A.M. Bertoli-Avella B.A. Oostra P. Heutink Chasing genes in Alzheimer's and Parkinson's disease Hum Genet 114 5 2004 413-438
38. J.L. Kennedy L.A. Farrer N.C. Andreasen R. Mayeux P. George-Hyslop The genetics of adult-onset neuropsychiatric disease: Complexities and conundra? Science 302 5646 2003 822-826
39. M. Citron Strategies for disease modification in Alzheimer's disease Nat Rev Neurosci 5 9 2004 677-685
40. R.L. Nussbaum C.E. Ellis Alzheimer's disease and Parkinson's disease N Engl J Med 348 14 2003 1356-1364
41. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 7000 2004 631-639
42. D.L. Price S.S. Sisodia Mutant genes in familial Alzheimer's disease and transgenic models Annu Rev Neurosci 21 1998 479-505
43. D.J. Selkoe Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases Nat Cell Biol 6 11 2004 1054-1061
44. V.M. Lee M. Goedert J.Q. Trojanowski Neurodegenerative tauopathies Annu Rev Neurosci 24 2001 1121-1159
45. B.I. Giasson V.M. Lee J.Q. Trojanowski Interactions of amyloidogenic proteins Neuromolecular Med 4 1-2 2003 49-58
46. D.J. Selkoe D. Schenk Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics Annu Rev Pharmacol Toxicol 43 2003 545-584
47. V. John J.P. Beck M.J. Bienkowski S. Sinha R.L. Heinrikson Human beta-secretase (BACE) and BACE inhibitors J Med Chem 46 22 2003 4625-4630
48. M. Ohno E.A. Sametsky L.H. Younkin H. Oakley S.G. Younkin M. Citron et al. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease Neuron 41 1 2004 27-33
49. L. Puglielli R.E. Tanzi D.M. Kovacs Alzheimer's disease: The cholesterol connection Nat Neurosci 6 4 2003 345-351
50. K.A. Crutcher Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease J Mol Neurosci 23 3 2004 181-188
51. R.E. Tanzi R.D. Moir S.L. Wagner Clearance of Alzheimer's Abeta peptide: the many roads to perdition Neuron 43 5 2004 605-608
52. R.B. DeMattos J.R. Cirrito M. Parsadanian P.C. May M.A. O'Dell J.W. Taylor et al. ApoE and clusterin cooperatively suppress abeta levels and deposition. Evidence that ApoE regulates extracellular abeta metabolism in vivo Neuron 41 2 2004 193-202
53. E.M. Ingram M.G. Spillantini Tau gene mutations: Dissecting the pathogenesis of FTDP-17 Trends Mol Med 8 12 2002 555-562
54. J.C. van Swieten S.M. Rosso E. van Herpen W. Kamphorst R. Ravid P. Heutink Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17 Dement Geriatr Cogn Disord 17 4 2004 261-264
55. A. Kertesz W. Davidson P. McCabe D. Munoz Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia Alzheimer Dis Assoc Disord 17 4 2003 223-229
56. M. Goedert Tau protein and neurodegeneration Semin Cell Dev Biol 15 1 2004 45-49
57. V.M. Van Deerlin L.H. Gill J.M. Farmer J.Q. Trojanowski V.M. Lee Familial frontotemporal dementia: From gene discovery to clinical molecular diagnostics Clin Chem 49 10 2003 1717-1725
58. D.C. German A.J. Eisch Mouse models of Alzheimer's disease: Insight into treatment Rev Neurosci 15 5 2004 353-369
59. C. Casas N. Sergeant J.M. Itier V. Blanchard O. Wirths K.N. van der et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model Am J Pathol 165 4 2004 1289-1300
60. F. Trinchese S. Liu F. Battaglia S. Walter P.M. Mathews O. Arancio Progressive age-related development of Alzheimer-like pathology in APP/ PS1 mice Ann Neurol 55 6 2004 801-814
61. J.L. Jankowsky H.H. Slunt V. Gonzales N.A. Jenkins N.G. Copeland D.R. Borchelt APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1 Neurobiol Aging 25 7 2004 885-892
62. S. Oddo L. Billings J.P. Kesslak D.H. Cribbs F.M. LaFerla Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome Neuron 43 3 2004 321-332
63. J. Lewis D.W. Dickson W.L. Lin L. Chisholm A. Corral G. Jones et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 5534 2001 1487-1491
64. J. Hardy Toward Alzheimer therapies based on genetic knowledge Annu Rev Med 55 2004 15-25
65. J. Hardy Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? Eur J Nucl Med Mol Imaging 31 11 2004 1539-1540
66. M. Vila S. Przedborski Genetic clues to the pathogenesis of Parkinson's disease Nat Med 10 2004 S58-S62
67. T.M. Dawson V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 5646 2003 819-822
68. J.Q. Trojanowski V.M. Lee Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses Neurotoxicology 23 4-5 2002 457-460
69. W. Dauer S. Przedborski Parkinson's disease, Mechanisms and models Neuron 39 6 2003 889-909
70. S. Shimohama H. Sawada Y. Kitamura T. Taniguchi Disease model: Parkinson's disease Trends Mol Med 9 8 2003 360-365
71. D.J. Moore V.L. Dawson T.M. Dawson Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses Neuromolecular Med 4 1-2 2003 95-108
72. K.A. Jellinger Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: Incidence and topographic distribution - a pilot study Acta Neuropathol (Berl) 106 3 2003 191-201
73. M.H. Polymeropoulos C. Lavedan E. Leroy S.E. Ide A. Dehejia A. Dutra et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045-2047
74. R. Kruger W. Kuhn T. Muller D. Woitalla M. Graeber S. Kosel et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat Genet 18 2 1998 106-108
75. J.J. Zarranz J. Alegre J.C. Gomez-Esteban E. Lezcano R. Ros I. Ampuero et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 2 2004 164-173
76. M.G. Spillantini M.L. Schmidt V.M. Lee J.Q. Trojanowski R. Jakes M. Goedert Alpha-synuclein in Lewy bodies Nature 388 6645 1997 839-840
77. A.B. Singleton M. Farrer J. Johnson A. Singleton S. Hague J. Kachergus et al. alpha-Synuclein locus triplication causes Parkinson's disease Science 302 5646 2003 841
78. M.C. Chartier-Harlin J. Kachergus C. Roumier V. Mouroux X. Douay S. Lincoln et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 9440 2004 1167-1169
79. A. Singleton A. Myers J. Hardy The law of mass action applied to neurodegenerative disease: A hypothesis concerning the etiology and pathogenesis of complex diseases Hum Mol Genet 13 2004 R123-R126 [Spec No 1]
80. T. Kitada S. Asakawa N. Hattori H. Matsumine Y. Yamamura S. Minoshima et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 6676 1998 605-608
81. M. Farrer P. Chan R. Chen L. Tan S. Lincoln D. Hernandez et al. Lewy bodies and parkinsonism in families with parkin mutations Ann Neurol 50 3 2001 293-300
82. J.T. Greenamyre T.G. Hastings Parkinson's - divergent causes, convergent mechanisms Science 304 5674 2004 1120-1122
83. A. Zimprich S. Biskup P. Leitner P. Lichtner M. Farrer S. Lincoln et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 4 2004 601-607
84. C. Paisan-Ruiz S. Jain E.W. Evans W.P. Gilks J. Simon B.M. van der et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 4 2004 595-600
85. Z.K. Wszolek R.F. Pfeiffer Y. Tsuboi R.J. Uitti R.D. McComb A.J. Stoessl et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology Neurology 62 9 2004 1619-1622
86. K.K. Chung Y. Zhang K.L. Lim Y. Tanaka H. Huang J. Gao et al. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Nat Med 7 10 2001 1144-1150
87. S. Engelender Z. Kaminsky X. Guo A.H. Sharp R.K. Amaravi J.J. Kleiderlein et al. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions Nat Genet 22 1 1999 110-114
88. D.A. Di Monte The environment and Parkinson's disease: Is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2 9 2003 531-538
89. H.H. Liou M.C. Tsai C.J. Chen J.S. Jeng Y.C. Chang S.Y. Chen et al. Environmental risk factors and Parkinson's disease: A case-control study in Taiwan Neurology 48 6 1997 1583-1588
90. H. Petrovitch G.W. Ross R.D. Abbott W.T. Sanderson D.S. Sharp C.M. Tanner et al. Plantation work and risk of Parkinson disease in a population-based longitudinal study Arch Neurol 59 11 2002 1787-1792
91. R. Betarbet T.B. Sherer G. MacKenzie M. Garcia-Osuna A.V. Panov J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 12 2000 1301-1306
92. C. Perier J. Bove M. Vila S. Przedborski The rotenone model of Parkinson's disease Trends Neurosci 26 7 2003 345-346
93. D.J. Moore L. Zhang J. Troncoso M.K. Lee N. Hattori Y. Mizuno et al. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress Hum Mol Genet 14 1 2005 71-84
94. K.K. Chung B. Thomas X. Li O. Pletnikova J.C. Troncoso L.S. Marsh et al. nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function Science 304 5675 2004 1328-1331
95. A. Jablensky The 100-year epidemiology of schizophrenia Schizophr Res 28 2-3 1997 111-125
96. K.T. Mueser S.R. McGurk Schizophrenia Lancet 363 9426 2004 2063-2072
97. H.W. An Der H. Hafner The epidemiology of onset and course of schizophrenia Eur Arch Psychiatry Clin Neurosci 250 6 2000 292-303
98. P.J. Harrison D.R. Weinberger Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence Mol Psychiatry 2004
99. I.C. Wright S. Rabe-Hesketh P.W. Woodruff A.S. David R.M. Murray E.T. Bullmore Meta-analysis of regional brain volumes in schizophrenia Am J Psychiatry 157 1 2000 16-25
100. G.D. Pearlson L. Marsh Structural brain imaging in schizophrenia: A selective review Biol Psychiatry 46 5 1999 627-649
101. P.F. Sullivan K.S. Kendler M.C. Neale Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies Arch Gen Psychiatry 60 12 2003 1187-1192
102. T.D. Cannon J. Kaprio J. Lonnqvist M. Huttunen M. Koskenvuo The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study Arch Gen Psychiatry 55 1 1998 67-74
103. A.G. Cardno E.J. Marshall B. Coid A.M. Macdonald T.R. Ribchester N.J. Davies et al. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series Arch Gen Psychiatry 56 2 1999 162-168
104. R. Yolken Viruses and schizophrenia: A focus on herpes simplex virus Herpes 11 Suppl 2 2004 83A-88A
105. F.B. Dickerson J.J. Boronow C. Stallings A.E. Origoni I. Ruslanova R.H. Yolken Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia Arch Gen Psychiatry 60 5 2003 466-472
106. L. Arseneault M. Cannon J. Witton R.M. Murray Causal association between cannabis and psychosis: Examination of the evidence Br J Psychiatry 184 2004 110-117
107. T.D. Cannon P. Jones R.M. Murray Obstetric complications and schizophrenia: Historical and meta-analytic review Am J Psychiatry 159 2002 1080-1092
108. L.E. Scutt E.W. Chow R. Weksberg W.G. Honer A.S. Bassett Patterns of dysmorphic features in schizophrenia Am J Med Genet 105 8 2001 713-723
109. J. Schiffman E. Walker M. Ekstrom F. Schulsinger H. Sorensen S. Mednick Childhood Videotaped Social and Neuromotor Precursors of Schizophrenia: A Prospective Investigation Am J Psychiatry 161 11 2004 2021-2027
110. E.F. Walker T. Savoie D. Davis Neuromotor precursors of schizophrenia Schizophr Bull 20 3 1994 441-451
111. T.J. Raedler M.B. Knable D.R. Weinberger Schizophrenia as a developmental disorder of the cerebral cortex Curr Opin Neurobiol 8 1 1998 157-161
112. C.A. Ross G.D. Pearlson Schizophrenia, the heteromodal association neocortex and development: Potential for a neurogenetic approach Trends Neurosci 19 1996 171-176
113. P.J. Harrison M.J. Owen Genes for schizophrenia? Recent findings and their pathophysiological implications The Lancet 361 9355 2003 417-419
114. J.A. Lieberman Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective Biol Psychiatry 46 6 1999 729-739
115. T.E. Goldberg M.F. Egan T. Gscheidle R. Coppola T. Weickert B.S. Kolachana et al. Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia Arch Gen Psychiatry 60 9 2003 889-896
116. P.J. Moberg R. Agrin R.E. Gur R.C. Gur B.I. Turetsky R.L. Doty Olfactory dysfunction in schizophrenia: A qualitative and quantitative review Neuropsychopharmacology 21 3 1999 325-340
117. R.E. Scheffer Abnormal neurological signs at the onset of psychosis Schizophr Res 70 1 2004 19-26
118. J.A. Sweeney B. Luna N.M. Srinivasagam M.S. Keshavan N.R. Schooler G.L. Haas et al. Eye tracking abnormalities in schizophrenia: Evidence for dysfunction in the frontal eye fields Biol Psychiatry 44 8 1998 698-708
119. R. Freedman L.E. Adler S. Leonard Alternative phenotypes for the complex genetics of schizophrenia Biol Psychiatry 45 5 1999 551-558
120. C.G. Kohler W. Bilker M. Hagendoorn R.E. Gur R.C. Gur Emotion recognition deficit in schizophrenia: Association with symptomatology and cognition Biol Psychiatry 48 2 2000 127-136
121. G. Winterer M.F. Egan T. Raedler C. Sanchez D.W. Jones R. Coppola et al. P300 and genetic risk for schizophrenia Arch Gen Psychiatry 60 11 2003 1158-1167
122. P. Tienari L.C. Wynne K. Laksy J. Moring P. Nieminen A. Sorri et al. Genetic boundaries of the schizophrenia spectrum: Evidence from the Finnish Adoptive Family Study of Schizophrenia Am J Psychiatry 160 9 2003 1587-1594
123. R. Nicolson M. Lenane S.D. Hamburger T. Fernandez J. Bedwell J.L. Rapoport Lessons from childhood-onset schizophrenia Brain Res Brain Res Rev 31 2-3 2000 147-156
124. J.K. Millar R. James N.J. Brandon P.A. Thomson DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness Ann Med 36 5 2004 367-378
125. D.H. Blackwood A. Fordyce M.T. Walker D.M. St Clair D.J. Porteous W.J. Muir Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family Am J Hum Genet 69 2 2001 428-433
126. J.K. Millar J.C. Wilson-Annan S. Anderson S. Christie M.S. Taylor C.A. Semple et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia Hum Mol Genet 9 9 2000 1415-1423
127. J. Ekelund I. Hovatta A. Parker T. Paunio T. Varilo R. Martin et al. Chromosome 1 loci in Finnish schizophrenia families Hum Mol Genet 10 15 2001 1611-1617
128. J. Ekelund W. Hennah T. Hiekkalinna A. Parker J. Meyer J. Lonnqvist et al. Replication of 1q42 linkage in Finnish schizophrenia pedigrees Mol Psychiatry 11 2004 1037-1041
129. H.G. Hwu C.M. Liu C.S. Fann W.C. Ou-Yang S.F. Lee Linkage of schizophrenia with chromosome 1q loci in Taiwanese families Mol Psychiatry 8 4 2003 445-452
130. C.P. Austin B. Ky L. Ma J.A. Morris P.J. Shughrue Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development Neuroscience 124 1 2004 3-10
131. S. Macgregor P.M. Visscher S.A. Knott P. Thomson D.J. Porteous J.K. Millar et al. genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42 Mol Psychiatry 9 12 2004 1083-1090
132. C.A. Hodgkinson D. Goldman J. Jaeger S. Persaud J.M. Kane R.H. Lipsky et al. Disrupted in Schizophrenia 1 (DISC1): Association with Schizophrenia, schizoaffective disorder, and bipolar disorder Am J Hum Genet 75 5 2004
133. Y. Ozeki T. Tomoda J. Kleiderlein A. Kamiya L. Bord K. Fujii et al. From the Cover: Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth Proc Natl Acad Sci USA 100 1 2003 289-294
134. I.L. Schurov E.J. Handford N.J. Brandon P.J. Whiting Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment Mol Psychiatry 9 12 2004 1100-1110
135. Y. Ozeki T. Tomoda J. Kleiderlein A. Kamiya L. Bord K. Fujii et al. Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth Proc Natl Acad Sci USA 100 1 2003 289-294
136. J.A. Morris G. Kandpal L. Ma C.P. Austin DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: Regulation and loss of interaction with mutation Hum Mol Genet 12 13 2003 1591-1608
137. N.J. Brandon E.J. Handford I. Schurov J.C. Rain M. Pelling B. Duran-Jimeniz et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: Implications for schizophrenia and other major neurological disorders Mol Cell Neurosci 25 1 2004 42-55
138. M.D. Nguyen T. Shu K. Sanada R.C. Lariviere H.C. Tseng S.K. Park et al. NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons Nat Cell Biol 6 7 2004 595-608
139. Y. Liang W. Yu Y. Li Z. Yang X. Yan Q. Huang et al. Nudel functions in membrane traffic mainly through association with Lis1 and cytoplasmic dynein J Cell Biol 164 4 2004 557-566
140. O. Reiner A. Cahana T. Escamez S. Martinez LIS1-no more no less Mol Psychiatry 7 1 2002 12-16
141. S. Sasaki A. Shionoya M. Ishida M.J. Gambello J. Yingling A. Wynshaw-Boris et al. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system Neuron 28 3 2000 681-696
142. X. Yan F. Li Y. Liang Y. Shen X. Zhao Q. Huang et al. Human Nudel and NudE as regulators of cytoplasmic dynein in poleward protein transport along the mitotic spindle Mol Cell Biol 23 4 2003 1239-1250
143. K. Toyooka Y. Watanabe S. Iritani E. Shimizu M. Iyo R. Nakamura et al. A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients Neurosci Res 46 3 2003 299-307
144. N. Sawamura T. Sawamura-Yamamoto Y. Ozeki C.A. Ross A. Sawa A form of DISC1 enriched in nucleus: Altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse Proc Natl Acad Sci U S A 102 4 2005 1187-1192
145. N. Sachs A. Sawa S.E. Holmes C.A. Ross L. DeLisi R.L. Margolis A frameshift mutation in Disrupted in Schizophrenia 1 in an American Family with schizophrenia and schizoaffective disorder Mol Psychiatry 10 8 2005 758-764
146. Sawa A, Sawamura N, Balkissoon R. Disrupted-In-Schizophrenia-1 (DISC1): a promising lead in molecular analyses of schizophrenia. Clinical Neuroscience Research. 2005.
147. J. Sebat B. Lakshmi J. Troge J. Alexander J. Young P. Lundin et al. Large-scale copy number polymorphism in the human genome Science 305 5683 2004 525-528
148. J.K. Cowell Y.D. Wang K. Head J. Conroy D. McQuaid N.J. Nowak Identification and characterisation of constitutional chromosome abnormalities using arrays of bacterial artificial chromosomes Br J Cancer 90 4 2004 860-865